NEXT

Amaris Elliott Engel

Amaris Elliott Engel

July 31, 2014 | Connecticut Law Tribune

Attorney Hit With Financial Penalty After Making Bias Claim

A federal judge has sanctioned a civil rights attorney for alleging that the Bridgeport Board of Education will not hire any private practice African-American attorneys to handle its cases, including her.

By Amaris Elliott-Engel

2 minute read

July 30, 2014 | National Law Journal

Compound Manufacturer to Resolve Asbestos-Related Bankruptcy

RPM International Inc. has announced that two of its subsidiaries have reached an agreement to resolve their liability for asbestos exposure by setting up a bankruptcy trust seeded with $797.5 million in cash or stock.

By Amaris Elliott-Engel

2 minute read

July 30, 2014 | National Law Journal

Dialysis Defendant Objects to 'Adverse Event' Discovery

An operator of dialysis clinic argues it should not have to produce hard copies of information about “adverse events” involving its patients because it would require searching records at 2,100 clinics with a client base of 170,000 patients in 2013.

By Amaris Elliott-Engel

2 minute read

July 30, 2014 | National Law Journal

Court: Asbestos Trial Prejudiced Against Supplier

The Delaware Supreme Court has ordered a new asbestos trial for the manufacturer of industrial talc because the trial judge did not instruct the jury about a codefendant's duty of care to the plaintiff.

By Amaris Elliott-Engel

3 minute read

July 30, 2014 | National Law Journal

Judge Rejects Diet Drug Plaintiff's Claims

A plaintiff in the 15-year-old litigation over Pfizer's Fen-Phen diet drugs has lost his effort to obtain $776,000 in benefits from a settlement trust formed by Pfizer's Wyeth wholly owned subsidiary. The U.S. Food and Drug Administration in September 1997 ordered the drugs withdrawn from the market because of an association with heart valve disease.

By Amaris Elliott-Engel

2 minute read

July 30, 2014 | National Law Journal

Pharmacy Software Company Might Be Liable for Side-Effect

A California appeals court has ruled that a software company that provided a program to distribute drug information to pharmacy customers might be liable to a plaintiff who received truncated warnings about a drug's risks.

By Amaris Elliott-Engel

3 minute read

July 29, 2014 | National Law Journal

Law Firm's Withdrawal from Gun Liability Lawsuit Upheld

Morgan Lewis & Bockius was entitled to withdraw from representing a Turkish arms manufacturer that still owes $25 million on a three-decades-old products liability and civil contempt judgment, the U.S. Court of Appeals for the Third Circuit has ruled.

By Amaris Elliott-Engel

2 minute read

July 29, 2014 | National Law Journal

First Circuit Green-Lights Cable Outage Class Action

The U.S. Court of Appeals for the First Circuit has ruled that Charter Communications Inc. and a subsidiary must defend a class action filed by customers claiming they should have been extended billing credits because their cable, Internet and telephone service was disrupted during a Massachusetts snowstorm.

By Amaris Elliott-Engel

2 minute read

July 28, 2014 | National Law Journal

Lawyers Settle Fight Over $62 Million In Fees

Lead lawyers in the litigation over hormone replacement therapy drugs have agreed to resolve their dispute involving $62.3 million in fees for work performed for the plaintiffs' common benefit.

By Amaris Elliott-Engel

3 minute read

July 28, 2014 | National Law Journal

Plaintiffs: $9B Verdict Against Drugmakers is Fair

Plaintiffs who won $9 billion in punitive damages in the first federal bellwether trial over diabetes drug Actos said the verdict should be upheld because there is no bright-line rule that punitive damages have to be in a single-digit ratio with compensatory damages.

By Amaris Elliott-Engel

3 minute read


More from ALM